Corbenic Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core Dividend Growth ETF
DGRO
|
+$3.75M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$3.61M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.85M |
| 4 |
Home Depot
HD
|
+$1.52M |
| 5 |
JPMorgan Chase
JPM
|
+$892K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.34M |
| 2 |
CVS Health
CVS
|
+$618K |
| 3 |
Pfizer
PFE
|
+$190K |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$123K |
| 5 |
NVIDIA
NVDA
|
+$107K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.81% |
| 2 | Consumer Discretionary | 8.91% |
| 3 | Healthcare | 6% |
| 4 | Communication Services | 5.2% |
| 5 | Utilities | 3.87% |
Similar funds
Corbenic Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Corbenic Partners held 209 positions worth $242M, up 16% from $208M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Corbenic Partners deployed $13M of net new capital in Q4 2020, opening 38 new positions and adding to 39 existing holdings. Its largest new stake was PIMCO Active Bond Exchange-Traded Fund: 2,683 shares worth $304K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $1.34M trimmed.
- Corbenic Partners's largest Q4 2020 buy was PIMCO Active Bond Exchange-Traded Fund: 2,683 shares worth $304K.
- Corbenic Partners added most to iShares Core Dividend Growth ETF in Q4 2020, an estimated $3.75M increase.
- Corbenic Partners's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $1.34M.
- Corbenic Partners fully exited Mesoblast in Q4 2020, selling an estimated $56K.
- Corbenic Partners's ten largest holdings make up 65% of its $242M portfolio in Q4 2020.
- Corbenic Partners opened 38 new positions and closed 13 in Q4 2020.
- Corbenic Partners's portfolio value rose 16% quarter-over-quarter to $242M.
Based on Corbenic Partners's 13F filing for Q4 2020, filed 29 Jan 2021.